LC

(redirected from colitis)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.

LC

abbreviation for LORD CHANCELLOR.
References in periodicals archive ?
ScotRail's U-turn on their promise of free public toilets will be distressing for many people living with Crohn's or colitis and other chronic health conditions.
Release date- 08082019 - Osaka - Takeda Pharmaceutical Company Limited ('Takeda') (TSE: 4502/NYSE: TAK) today announced that it has submitted a New Drug Application (NDA) to the Ministry of Health, Labour and Welfare in Japan for a subcutaneous (SC) formulation of vedolizumab, a gut-selective biologic for maintenance therapy in adults with moderately to severely active ulcerative colitis (UC).
The agency also said that the approved use of tofacitinib for ulcerative colitis will be restricted to certain patients who do not respond to, or who have severe side effects with, certain other medicines.
Ulcerative colitis and Crohn's disease are long-term conditions that involve inflammation of the gut.
Pharmaceutical company InDex Pharmaceuticals Holding AB (publ) said on Tuesday that it has enrolled its last ulcerative colitis patient under the dose optimisation cobitolimod study CONDUCT.
The data set excluded patients with indeterminate colitis or who underwent colectomy for ulcerative colitis.
The data presented from the Phase 3 UNIFI study of STELARA in ulcerative colitis has been included in our regulatory applications in the U.S., EU, Canada and Japan.
Ulcerative colitis affects the large intestine and causes irritation and swelling called inflammation whereas Crohn's disease is a chronic inflammatory bowel disease (IBD) characterised by inflammation that responds to tissue injury ultimately causing redness, swelling, and pain.
Studies have indicated that curcumin application can ameliorate intestinal inflammation condition in the murine colitis model and in patients with IBD along with regular therapy (9,10).
Immuno-inflammation company I-Mab Biopharma revealed on Thursday that it has dosed the first patient in China under its phase II clinical trial of TJ301 for the treatment of Ulcerative Colitis (UC), a chronic inflammatory bowel disease.
M2 EQUITYBITES-October 12, 2018-I-Mab Biopharma treats the first ulcerative colitis patient in China under its phase II clinical trial of TJ301
ISLAMABAD -- Insulin, which plays a key role in managing blood sugar, also has potential against colitis a chronic bowel inflammation, said a study.